Kathy D. Miller, MD, relates a patient experience that underscores the connection between proper patient evaluation and efficacious treatment for advanced and metastatic breast cancer.
In this case, the information gained by a relatively novel genetic test authorized the direct move to a single-agent protocol with pembrolizumab, which in turn produced a complete pathologic response in the patient.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: How Genetic Testing Impacts Treatment Strategies for Advanced and Metastatic Breast Cancer - Medscape - Jul 28, 2022.